EP0000984B1 - Programmable pacer with variable amplifier gain - Google Patents

Programmable pacer with variable amplifier gain Download PDF

Info

Publication number
EP0000984B1
EP0000984B1 EP19780300237 EP78300237A EP0000984B1 EP 0000984 B1 EP0000984 B1 EP 0000984B1 EP 19780300237 EP19780300237 EP 19780300237 EP 78300237 A EP78300237 A EP 78300237A EP 0000984 B1 EP0000984 B1 EP 0000984B1
Authority
EP
European Patent Office
Prior art keywords
pacemaker
signals
heart
input amplifier
signal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
EP19780300237
Other languages
German (de)
French (fr)
Other versions
EP0000984A1 (en
Inventor
John Walter Keller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotronik SE and Co KG
Original Assignee
Biotronik Mess und Therapiegeraete GmbH and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/917,142 external-priority patent/US4202342A/en
Application filed by Biotronik Mess und Therapiegeraete GmbH and Co filed Critical Biotronik Mess und Therapiegeraete GmbH and Co
Publication of EP0000984A1 publication Critical patent/EP0000984A1/en
Application granted granted Critical
Publication of EP0000984B1 publication Critical patent/EP0000984B1/en
Expired legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37211Means for communicating with stimulators

Definitions

  • This invention relates to cardiac pacemakers.
  • Pacemakers for generating artificial stimulating pulses for the heart, and which may be implanted in the body, are well known.
  • the electrical circuitry for such pacemakers was of analog design, but in recent years digital circuitry has been also employed.
  • a digital approach to pacemakers has led to the evolution of programmable pacemakers-pacemakers having parameters such as pulse rates which are adjustable (programmable) once the pacemaker has been implanted.
  • the programs can be changed from outside the patient's body by appropriate signal transmission to the implanted pacemaker and without surgery.
  • Programmable pacemakers are described in for instance, British Specifications 1,385,954 and 1,398,875.
  • Such pacemakers have circuitry to detect and decode signals transmitted outside the body and alter the program accordingly.
  • pacemakers are of the demand type- that is they only supply a stimulating pulse to the heart when a natural heart beat is absent. To accomplish this, demand pacemakers have means for sensing the presence or absence of natural heat beats and for actuating the stimulating pulse as appropriate.
  • Demand pacemakers normally have an input amplifier which receives the electrical signals detected at the heart, and the amplified signals are then employed to control the demand function of the pacemaker.
  • signals provided by the input amplifier are employed to inhibit any artificial pulse being generated by the pacemaker: the absence of such signals being taken by the pacemaker as indicating the absence of a normal heart beat and causing artificial stimulating pulses to be generated.
  • Pacemakers are implanted in the body for a period of years, and during that time various parameters can change causing the effective signals supplied by the input amplifier to change in magnitude. Typical of such parameters is an increase in impedance of the body tissue as "seen" by the pacing electrode. But most prevalent is the wide range of electrode placement effectiveness which can result in not only very large but very small signals.
  • U.S. Patent 4,049,004 describes an implantable cardiac pacemaker with a number of externally programmable pacemaker functions including the sensitivity of the pacemaker response to signals at the heart.
  • the pacemaker includes an R-wave input amplifier constructed as an operational amplifier whose output is employed for resetting the stimulating pulse generator, thereby giving the pacemaker a demand capability.
  • the output of the operational amplifier is supplied to a field effect transistor whose switching threshold is varied from a master parameter control.
  • the latter is a memory store whose contents may be varied after implantation from a remote source of programming signals. This arrangement has no effect on the overall amplification provided to the signal supplied to the R-wave amplifier and can cause erroneous control of the pacemaker in certain operational states.
  • the field effect transistor can cut off the signal which should be employed to reset the pulse generator.
  • a pacemaker circuit which enables the signal supplied by the input amplifier to be changed after implantation and which does enable, for example, input signals of small magnitude to be handled at increased amplification or without the risk of cutting off the signal to be employed for resetting the pulse generator. This has been accomplished by providing different levels of attenuation for the signal supplied to the input amplifier and by selecting the desired attenuation by means of a program held in a pacemaker memory store.
  • an implantable cardiac pacemaker having a pacemaker function programmably alterable from a remote source of pacemaker function programming signals, comprising pulse generating means (1, 2, 3, 4,) for periodically issuing stimulating pulses, an input amplifier (12) for sensing signals at the heart and for resetting said generating means in response to a sensed signal, and memory means (18) responsive to signals from said remote source for varying the signal provided by the input amplifier for resetting said pulse generating means, characterised in that said varying means comprises a potential dividing network (11, 14) provided with an intermediate tap connected to the input of said input amplifier (12), means (13) connecting one extremity of said network to sense signals at the heart, and means (15, 16, 17) connected to apply to the other extremity of said network a potential controlled by an output signal of said memory means (18) for controlling the magnitude of the sensed heart signal applied to the input amplifier.
  • the pacemaker comprises an oscillator 1 which clocks a ripple counter 2.
  • Various outputs from the ripple counter are combined as is known in the art by means of logic gates (not shown) to provide four output lines 3.
  • the oscillator frequency and combination of ripple counter outputs are selected so that the four output lines 3 provide, respectively, body stimulation pulses at four different frequencies (e.g. 50, 60, 70, 80 pulses per minute).
  • the four output lines 3 are supplied to a rate decoder 4 provided with two input control lines 5.
  • the logic levels on lines 5 can be employed to select uniquely one from four of the four lines 3 and transmit the selected pulse frequency on line 6.
  • Line 6 is connected to an output amplifier 7 which in turn is connected to a connection 8 which leads to an active stimulating pulse electrode (not shown) disposed in or on the heart.
  • Line 6 also provides one input to an OR gate 9.
  • OR gate 9 The output of OR gate 9 is supplied to a delay unit 10 whose output is employed to reset counter 2.
  • the delay generated by delay unit 10 sets the pulse width for each artificial stimulating pulse which is transmitted on output line 6.
  • the active electrode disposed in or on the heart feeds back the electrical signals detected at the heart (arising from an artificial stimulating pulse or a natural heart beat) to the pacemaker via a resistor 11 (R1).
  • the output of resistor R 1 is connected to an input amplifier 12 which in turn supplies a second input to OR gate 9.
  • the feedback loop for such signals through the active electrode is illustrated by means of line 13.
  • a second resistor 14 Connected to input amplifier 12 is a second resistor 14 (R 2 ), which is connected via a capacitor 15 to the drain of a field effect transistor 16, the source of which is connected to Vpp.
  • the gate of the transistor 16 is controlled by a control line 17 which, as with control lines 5, extends from a pacemaker program store 18.
  • the program store 18 is arranged to hold, as a pacemaker program, a series of binary values for supply on the control lines 5 and 17.
  • a receiver/decoder 19 is arranged to receive and decode data signals transmitted from outside the patient's body to the implanted pacemaker, and to employ the decoded signals for changing a pacemaker program held in program store 18.
  • the data signals may be transmitted to the receiver/decoder 19 by any suitable means, but preferably we employ data signals transmitted by tone burst modulation (pulse width modulation of a carrier frequency).
  • the pacemaker operates as follows. A program is entered and held in the program store 18 and the binary levels on control lines 5 determine which one of the four outputs 3 derived from counter 2 is passed by rate decoder 4 onto output line 6.
  • the counter 2 In the absence of natural heart beats, the counter 2 successively generates a series of artificial pulses at the selected rate and these are supplied to the heart via output amplifier 7. Each artificial pulse causes a reset of counter 2 via OR gate 9 and delay 10 to enable the count for the next artificial pulse to commence.
  • the pacemaker operates in a normal demand mode-issuing artificial pulses only when demanded by the heart. It is of no consequence if the reset initiated by a natural heart beat arrives just as an artificial pulse is generated, since the natural beat and the stimulating pulse will essentially coincide.
  • a "0" is held in the program store 18 and this causes attenuation of the input signal to amplifier 12.
  • the gain of amplifier 12 and other parameters of the circuit are set such that the attenuation is acceptable and that the attenuated signal received is still of sufficient magnitude to carry out its necessary function of controlling the demand function of the pacemaker.
  • the program is changed to "1", to cause R 2 to float and remove attenuation of the input signal.

Description

    Field of the invention
  • This invention relates to cardiac pacemakers.
  • Background art
  • Pacemakers for generating artificial stimulating pulses for the heart, and which may be implanted in the body, are well known. Originally the electrical circuitry for such pacemakers was of analog design, but in recent years digital circuitry has been also employed. A digital approach to pacemakers has led to the evolution of programmable pacemakers-pacemakers having parameters such as pulse rates which are adjustable (programmable) once the pacemaker has been implanted. The programs can be changed from outside the patient's body by appropriate signal transmission to the implanted pacemaker and without surgery. Programmable pacemakers are described in for instance, British Specifications 1,385,954 and 1,398,875. Such pacemakers have circuitry to detect and decode signals transmitted outside the body and alter the program accordingly. In British Specification 1,385,954 the programming is accomplished by means of a magnetic field which is sensed by a magnetic reed switch; the opening and closing of the switch providing programming pulses to a program store. In British Specification 1,398,875 the programming is by means of radio frequency transmission and reception.
  • Many pacemakers are of the demand type- that is they only supply a stimulating pulse to the heart when a natural heart beat is absent. To accomplish this, demand pacemakers have means for sensing the presence or absence of natural heat beats and for actuating the stimulating pulse as appropriate.
  • Demand pacemakers normally have an input amplifier which receives the electrical signals detected at the heart, and the amplified signals are then employed to control the demand function of the pacemaker. Generally, signals provided by the input amplifier are employed to inhibit any artificial pulse being generated by the pacemaker: the absence of such signals being taken by the pacemaker as indicating the absence of a normal heart beat and causing artificial stimulating pulses to be generated.
  • Pacemakers are implanted in the body for a period of years, and during that time various parameters can change causing the effective signals supplied by the input amplifier to change in magnitude. Typical of such parameters is an increase in impedance of the body tissue as "seen" by the pacing electrode. But most prevalent is the wide range of electrode placement effectiveness which can result in not only very large but very small signals.
  • U.S. Patent 4,049,004 describes an implantable cardiac pacemaker with a number of externally programmable pacemaker functions including the sensitivity of the pacemaker response to signals at the heart. The pacemaker includes an R-wave input amplifier constructed as an operational amplifier whose output is employed for resetting the stimulating pulse generator, thereby giving the pacemaker a demand capability. The output of the operational amplifier is supplied to a field effect transistor whose switching threshold is varied from a master parameter control. The latter is a memory store whose contents may be varied after implantation from a remote source of programming signals. This arrangement has no effect on the overall amplification provided to the signal supplied to the R-wave amplifier and can cause erroneous control of the pacemaker in certain operational states. For example, with input signals of small amplitude (and which desirably require increased amplification) and with the field effect transistor on its least sensitive setting, the signal supplied to the transistor by the R-wave amplifier will be insufficient to switch it on and thus would not reset the pulse generator as required. Under some circumstances, therefore, the field effect transistor can cut off the signal which should be employed to reset the pulse generator.
  • Disclosure of the invention
  • We have now devised a pacemaker circuit which enables the signal supplied by the input amplifier to be changed after implantation and which does enable, for example, input signals of small magnitude to be handled at increased amplification or without the risk of cutting off the signal to be employed for resetting the pulse generator. This has been accomplished by providing different levels of attenuation for the signal supplied to the input amplifier and by selecting the desired attenuation by means of a program held in a pacemaker memory store.
  • According to the invention there is provided an implantable cardiac pacemaker having a pacemaker function programmably alterable from a remote source of pacemaker function programming signals, comprising pulse generating means (1, 2, 3, 4,) for periodically issuing stimulating pulses, an input amplifier (12) for sensing signals at the heart and for resetting said generating means in response to a sensed signal, and memory means (18) responsive to signals from said remote source for varying the signal provided by the input amplifier for resetting said pulse generating means, characterised in that said varying means comprises a potential dividing network (11, 14) provided with an intermediate tap connected to the input of said input amplifier (12), means (13) connecting one extremity of said network to sense signals at the heart, and means (15, 16, 17) connected to apply to the other extremity of said network a potential controlled by an output signal of said memory means (18) for controlling the magnitude of the sensed heart signal applied to the input amplifier.
  • Although several levels of signal level attenuation are possible (and from which selection can be made), it has been found that two levels are sufficient in practice ("high" and "low"). Appropriate selection of one of these two levels can be accomplished simply by a single binary bit held in the program store.
  • Brief description of the drawing
  • Preferred features of the invention are illustrated, by way of example, in the accompanying drawing which shows schematically an electrical circuit diagram of an implantable demand cardiac pacemaker according to the invention.
  • Best mode of making the invention
  • Referring to the drawing, the pacemaker comprises an oscillator 1 which clocks a ripple counter 2. Various outputs from the ripple counter are combined as is known in the art by means of logic gates (not shown) to provide four output lines 3. The oscillator frequency and combination of ripple counter outputs are selected so that the four output lines 3 provide, respectively, body stimulation pulses at four different frequencies (e.g. 50, 60, 70, 80 pulses per minute). The four output lines 3 are supplied to a rate decoder 4 provided with two input control lines 5. By employing binary logic circuitry, the logic levels on lines 5 can be employed to select uniquely one from four of the four lines 3 and transmit the selected pulse frequency on line 6. Line 6 is connected to an output amplifier 7 which in turn is connected to a connection 8 which leads to an active stimulating pulse electrode (not shown) disposed in or on the heart. Line 6 also provides one input to an OR gate 9.
  • The output of OR gate 9 is supplied to a delay unit 10 whose output is employed to reset counter 2. The delay generated by delay unit 10 sets the pulse width for each artificial stimulating pulse which is transmitted on output line 6.
  • The active electrode disposed in or on the heart feeds back the electrical signals detected at the heart (arising from an artificial stimulating pulse or a natural heart beat) to the pacemaker via a resistor 11 (R1). The output of resistor R1 is connected to an input amplifier 12 which in turn supplies a second input to OR gate 9. The feedback loop for such signals through the active electrode is illustrated by means of line 13.
  • Connected to input amplifier 12 is a second resistor 14 (R2), which is connected via a capacitor 15 to the drain of a field effect transistor 16, the source of which is connected to Vpp. The gate of the transistor 16 is controlled by a control line 17 which, as with control lines 5, extends from a pacemaker program store 18. The program store 18 is arranged to hold, as a pacemaker program, a series of binary values for supply on the control lines 5 and 17.
  • A receiver/decoder 19 is arranged to receive and decode data signals transmitted from outside the patient's body to the implanted pacemaker, and to employ the decoded signals for changing a pacemaker program held in program store 18. For the purposes of illustration, the receiver/decoder 19 and store 18 have been depicted simply in functional box-form. The data signals may be transmitted to the receiver/decoder 19 by any suitable means, but preferably we employ data signals transmitted by tone burst modulation (pulse width modulation of a carrier frequency).
  • The pacemaker operates as follows. A program is entered and held in the program store 18 and the binary levels on control lines 5 determine which one of the four outputs 3 derived from counter 2 is passed by rate decoder 4 onto output line 6.
  • In the absence of natural heart beats, the counter 2 successively generates a series of artificial pulses at the selected rate and these are supplied to the heart via output amplifier 7. Each artificial pulse causes a reset of counter 2 via OR gate 9 and delay 10 to enable the count for the next artificial pulse to commence.
  • If a natural heart beat arises, an electrical signal is received by input amplifier 12 and counter 2 is reset (via OR gate 9 and delay 10) to inhibit any count in the process of being generated. Thus described, the pacemaker operates in a normal demand mode-issuing artificial pulses only when demanded by the heart. It is of no consequence if the reset initiated by a natural heart beat arrives just as an artificial pulse is generated, since the natural beat and the stimulating pulse will essentially coincide.
  • Should it be wished to vary the overall gain of the input amplifier, then this may be accomplished as follows. If a "1" is held in program store 18 for output on line 17 ("1"=VpD), then the gate voltage of transistor 16 equals VDD and maintains the latter non-conducting: the point "X" between capacitor 15 and transistor 16 drain "floats". In such a circumstance R2 has no influence on the magnitude of the input signal to input amplifier 12, as applied through resistor R1.
  • If a "0" is held in the program store 18 for output on line 17, transistor 16 conducts and this causes point "X" to be at VDD* The result of this is to cause R1 and R2 to act as a potential divider for the input signal, causing the input signal to the input amplifier to be attenuated.
  • In the normal circumstances, a "0" is held in the program store 18 and this causes attenuation of the input signal to amplifier 12. The gain of amplifier 12 and other parameters of the circuit are set such that the attenuation is acceptable and that the attenuated signal received is still of sufficient magnitude to carry out its necessary function of controlling the demand function of the pacemaker.
  • Should it be desired to increase the overall gain of the input amplifier (e.g. when there is an electrode displacement, or when the pacemaker batteries have suffered some loss of power after a relatively long period of use or when there is poor electrode placement, or the growth of tissue, all of which alter the signal "seen" by the pacemaker), then the program is changed to "1", to cause R2 to float and remove attenuation of the input signal.
  • It will be appreciated that the circuit described above has been described in simple form, schematically, for the purposes of clarity. Also, though the amplifiers have been shown as single-input components it is of course possible to employ two input amplifiers (e.g. differential amplifiers).

Claims (3)

1. An implantable cardiac pacemaker having a pacemaker function programmably alterable from a remote source of pacemaker function programming signals comprising pulse generating means (1, 2, 3, 4) for periodically issuing stimulating pulses, an input amplifier (12) for sensing signals at the heart and for resetting said generating means in response to a sensed signal, and varying means including memory means (18) responsive to signals from said remote source for varying the signal provided by the input amplifier (12) for resetting said pulse generating means, characterised in that said varying means comprises a potential dividing network (11, 14) provided with an intermediate tap connected to the input of said input amplifier (12), means (13) connecting one extremity of said network to sense signals at the heart, and means (15, 16, 17) connected to apply to the other extremity of said network a potential controlled by an output signal of said memory means (18) for controlling the magnitude of the sensed heart signal applied to the input amplifier.
2. An implantable cardiac pacemaker according to claim 1, characterised in that said means connected to apply a potential comprise a voltage source (VDD), a capacitor (15) connected on one side to said other extremity of said network, and a switch means (16) between said source (V DD) and the other side of said capacitor (X), said switch means (16) operating in response to the output signal of said memory means.
3. An implantable cardiac pacemaker according to claim 2, characterised in that said switch means (16) comprises a field effect transistor whose gate electrode receives (17) said output signal of said memory means.
EP19780300237 1977-08-19 1978-08-03 Programmable pacer with variable amplifier gain Expired EP0000984B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB3491777 1977-08-19
GB3491777 1977-08-19
US917142 1978-06-19
US05/917,142 US4202342A (en) 1977-08-19 1978-06-19 Programmable pacer with variable amplifier sensitivity and pacing rate

Publications (2)

Publication Number Publication Date
EP0000984A1 EP0000984A1 (en) 1979-03-07
EP0000984B1 true EP0000984B1 (en) 1983-05-11

Family

ID=26262494

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19780300237 Expired EP0000984B1 (en) 1977-08-19 1978-08-03 Programmable pacer with variable amplifier gain

Country Status (4)

Country Link
EP (1) EP0000984B1 (en)
AU (1) AU3895778A (en)
CA (1) CA1098591A (en)
DE (1) DE2862246D1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2440199A1 (en) * 1978-11-06 1980-05-30 Medtronic Inc ON-DEMAND CARDIAC STIMULATOR
US5080096A (en) * 1990-07-06 1992-01-14 Medtronic, Inc. Method and apparatus for accessing a nonvolatile memory
EP2851048B1 (en) 2013-09-19 2018-09-05 The Procter and Gamble Company Absorbent cores having material free areas

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3830242A (en) * 1970-06-18 1974-08-20 Medtronic Inc Rate controller and checker for a cardiac pacer pulse generator means
NL7700427A (en) * 1976-03-03 1977-09-06 Arco Med Prod Co PLANTABLE DIGITAL PASSENGER WHICH IS FITTED WITH EXTERNALLY SELECTABLE BUSINESS PARAMETERS.

Also Published As

Publication number Publication date
DE2862246D1 (en) 1983-06-16
AU3895778A (en) 1980-02-21
CA1098591A (en) 1981-03-31
EP0000984A1 (en) 1979-03-07

Similar Documents

Publication Publication Date Title
US4556063A (en) Telemetry system for a medical device
US5443486A (en) Method and apparatus to limit control of parameters of electrical tissue stimulators
US4606349A (en) Implantable cardiac pacer having dual frequency programming and bipolar/unipolar lead programmability
EP0800414B1 (en) Pacemaker with a modified tachycardia detection based on ffrw sensing
AU596933B2 (en) Oxygen sensing pacemaker
US4181133A (en) Programmable tachycardia pacer
US5016634A (en) Implantable medical device with means for telemetric transmission of data
US5243979A (en) Method and apparatus for implementing activity sensing in a pulse generator
EP0349130B1 (en) Implantable cardiac stimulator with automatic gain control
US5441525A (en) Pacemaker with vasovagal syncope detection
EP0559193B1 (en) Implantable pacemaker providing hysteresis in dual-chamber modes
US8046071B2 (en) Pacemaker passive measurement testing system
US4561444A (en) Implantable cardiac pacer having dual frequency programming and bipolar/linipolar lead programmability
SE451670B (en) HEART STIMULATOR WITH PREVIOUS CONTROL FUNCTION
ES456504A1 (en) Implantable digital cardiac pacer having externally selectible operaing parameters
EP0000984B1 (en) Programmable pacer with variable amplifier gain
EP0709114B1 (en) Dual chamber pacemaker system with improved switching between synchronous and asynchronous behavior
US4202342A (en) Programmable pacer with variable amplifier sensitivity and pacing rate
US4203448A (en) Programmably variable voltage multiplier for implanted stimulator
EP0879619B1 (en) Pacemaker system with special function rate response
JPH0344785B2 (en)
US4304237A (en) Dual mode programmable pacer
US4169480A (en) Demand pacer with programmable rate hysteresis
EP0000987A1 (en) Demand pacer with programmable rate hysteresis
EP0000985A1 (en) Program alteration security for programmable pacers

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): DE FR GB NL SE

17P Request for examination filed
GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Designated state(s): DE FR GB NL SE

REF Corresponds to:

Ref document number: 2862246

Country of ref document: DE

Date of ref document: 19830616

ET Fr: translation filed
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 19830731

Year of fee payment: 6

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Effective date: 19840804

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 19840828

Year of fee payment: 7

GBPC Gb: european patent ceased through non-payment of renewal fee
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 19860831

Year of fee payment: 9

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Effective date: 19880301

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19880429

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Effective date: 19881117

EUG Se: european patent has lapsed

Ref document number: 78300237.1

Effective date: 19850612

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 19971028

Year of fee payment: 20